|
Apr 19
|
Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K
|
|
Mar 21
|
Cosmos Health Commences Development of Cloudscreen 2.0, the New Iteration of its Next Generation AI Drug Repurposing Platform
|
|
Mar 19
|
Cosmos Health To Receive Regulatory Approval for C-Scrub Disinfectant in the UK, Obtains Initial Purchase Order; Explores Opportunities Outside EU, Eyeing Global $36Bn+ Market
|
|
Mar 18
|
Cosmos Health Receives Regulatory Approval to Sell Sky Premium Life Products in $1.9Bn UAE Nutritional Supplements Market; Secures Initial Purchase Orders
|
|
Jan 18
|
Cosmos Health Bolsters Presence in $400Bn+ Global Generic Drugs Market with $3.5M Acquisition of 10-Drug Portfolio
|
|
Dec 20
|
Cosmos Health Enters into Definitive Agreement to Acquire Type-2 Diabetes Treatment DIABIT-IS X
|
|
Dec 18
|
Cosmos Health Announces Open Market Stock Purchases by the CEO
|
|
Dec 8
|
Cosmos Health to Participate at Capital Link’s 'Invest in Greece' Forum in New York
|
|
Dec 7
|
Cosmos Health Enters into Agreement to Acquire Rights for WIPO-Filed Patent on Drug Targeting CNS Cancers
|
|
Dec 1
|
Cosmos Health Announces Patent Filing for its Obesity and Weight Management Product
|
|
Aug 8
|
Cosmos Health Appoints Big 4 Accounting Firm KPMG as Auditor
|
|
Mar 24
|
Cosmos Health Inc.'s UK Subsidiary Decahedron Ltd. Named Pharmaceutical Wholesaler of the Month in the Latest Issue of Healthcare Matters
|